Literature DB >> 16227216

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.

Mike M Pütz1, Isabella Alberini2, Claire M Midgley1, Ilaria Manini2, Emanuele Montomoli2, Geoffrey L Smith1.   

Abstract

Decades after smallpox was eradicated and vaccination discontinued, the level of residual immunity in today's population is largely unknown. This study describes an epidemiological assessment in Italians of antibodies against the intracellular mature virus (IMV) and extracellular envelope virus (EEV) forms of Vaccinia virus. Serum samples (n = 642) were taken in 1993 and 2003 from people between 11 and 102 years old. Most citizens >27 years old were positive for antibodies to IMV and EEV. These antibodies were long-lasting and similar titres were present in citizens between 30 and 100 years old. Serum samples from 1993 and 2003 displayed very similar EEV- and IMV-specific antibody titres. By using these data and demographic considerations, it was predicted that, in 2003, 46 % of the Italian population were positive for both IMV and EEV, 42 % were negative for both and 12 % were positive for one antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227216     DOI: 10.1099/vir.0.81265-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.

Authors:  Jesse D Troy; Heather R Hill; Marian G Ewell; Sharon E Frey
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

3.  Orthopox Viruses: Infections in Humans.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

4.  The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein.

Authors:  Kaori Shinoda; Linda S Wyatt; Bernard Moss
Journal:  Virology       Date:  2010-06-17       Impact factor: 3.616

5.  Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus.

Authors:  Xiangzhi Meng; Youmin Zhong; Addie Embry; Bo Yan; Shan Lu; Guangming Zhong; Yan Xiang
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

6.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

7.  CD4 and CD8 T cells participate in the immune memory response against Vaccinia virus after a previous natural infection.

Authors:  Daniela Carla Medeiros-Silva; Eduardo Augusto Dos Santos Moreira-Silva; Juliana de Assis Silva Gomes; Flávio Guimarães da Fonseca; Rodrigo Correa-Oliveira
Journal:  Results Immunol       Date:  2013-11-09

Review 8.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Authors:  Magdalini Moutaftsi; David C Tscharke; Kerrie Vaughan; David M Koelle; Lawrence Stern; Mauricio Calvo-Calle; Francis Ennis; Masanori Terajima; Gerd Sutter; Shane Crotty; Ingo Drexler; Genoveffa Franchini; Jon W Yewdell; Steven R Head; Janice Blum; Bjoern Peters; Alex Sette
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

9.  Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.

Authors:  Maria Cristina Ballesteros-Briones; Eva Martisova; Erkuden Casales; Noelia Silva-Pilipich; Maria Buñuales; Javier Galindo; Uxua Mancheño; Marta Gorraiz; Juan J Lasarte; Grazyna Kochan; David Escors; Alfonso R Sanchez-Paulete; Ignacio Melero; Jesus Prieto; Ruben Hernandez-Alcoceba; Sandra Hervas-Stubbs; Cristian Smerdou
Journal:  Mol Ther       Date:  2019-09-16       Impact factor: 11.454

10.  Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Authors:  Claire M Midgley; Mike M Putz; Jonathan N Weber; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.